Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) open the trading on July 13, 2021, with a bit cautious approach as it glided -3.64% to $1.59. During the day, the stock rose to $1.66 and sunk to $1.58 before settling in for the price of $1.65 at the close. Taking a more long-term approach, CRBP posted a 52-week range of $0.91-$9.78.It was noted that the giant of the Healthcare sector posted annual sales growth of 43.40% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -38.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -27.40%. This publicly-traded company’s shares outstanding now amounts to $125.03 million, simultaneously with a float of $123.76 million. The organization now has a market capitalization sitting at $191.91 million. At the time of writing, stock’s 50-day Moving Average stood at $1.8420, while the 200-day Moving Average is $1.7528.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 76 workers. It has generated 51,806 per worker during the last fiscal year. Meanwhile, its income per employee was -1,464,071. The stock had 1.50 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -3119.20 and Pretax Margin of -3174.04.
Corbus Pharmaceuticals Holdings Inc. (CRBP) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Corbus Pharmaceuticals Holdings Inc.’s current insider ownership accounts for 0.42%, in contrast to 46.90% institutional ownership. According to the most recent insider trade that took place on Dec 21, this organization’s Chief Financial Officer sold 87,500 shares at the rate of 1.75, making the entire transaction reach 153,125 in total value, affecting insider ownership by 349,610. Preceding that transaction, on Dec 18, Company’s Chief Financial Officer sold 53,610 for 1.40, making the whole transaction’s value amount to 75,054. This particular insider is now the holder of 349,610 in total.
Corbus Pharmaceuticals Holdings Inc. (CRBP) Earnings and Revenue Records
This company achieved a net margin of -2826.08 while generating a return on equity of -432.68.
Corbus Pharmaceuticals Holdings Inc.’s EPS decrease for this current 12-month fiscal period is -27.40% and is forecasted to reach -0.42 in the upcoming year.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Trading Performance Indicators
Let’s observe the current performance indicators for Corbus Pharmaceuticals Holdings Inc. (CRBP). It’s Quick Ratio in the last reported quarter now stands at 5.50. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 68.54.
In the same vein, CRBP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.18, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Corbus Pharmaceuticals Holdings Inc. (CRBP)
[Corbus Pharmaceuticals Holdings Inc., CRBP] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 14.02% While, its Average True Range was 0.1123.
Raw Stochastic average of Corbus Pharmaceuticals Holdings Inc. (CRBP) in the period of the previous 100 days is set at 13.69%, which indicates a major rise in contrast to 1.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.23% that was lower than 76.98% volatility it exhibited in the past 100-days period.